98%
921
2 minutes
20
Background: Individual studies on men with mildly symptomatic or asymptomatic inguinal hernia who have opted for watchful waiting (WW) vary considerably. Furthermore, long-term data on such patients who cross over to herniorrhaphy is scarce.
Methods: PubMed, EMBASE, and Cochrane databases were searched systematically from inception to 3rd April 2024 for long-term follow-up of randomized controlled trials (RCTs) on men with mildly symptomatic or asymptomatic inguinal hernia. Individual participant survival data of cross over rates from WW to herniorrhaphy were extracted, reconstructed and combined. Secondary outcome was reason for cross over to herniorrhaphy.
Results: Long-term follow-up of three RCTs with 592 participants was included. A total of 344/592 participants crossed over to herniorrhaphy during a median follow up period that ranged from 3.2 to 12.0 years. The median cumulative cross over rate was 54.2% (95% CI 45.5% - 66.3%). The cumulative 1-year, 5-year, and 10- year cross over rates were 28.7% (95% CI 25.2% - 32.5%), 51.5% (95% CI 47.4% - 55.6%), and 70.6% (95% CI 66.2% - 74.9%) respectively. During follow-up, the most frequent reasons for cross over to herniorrhaphy were increased pain 198/344 (57.6%) and incarceration 15/344 (4.4%).
Conclusion: This study provides valuable long-term data for patient counselling, indicating that while WW is a safe strategy for men with mildly symptomatic or asymptomatic inguinal hernia, symptoms would likely progress eventually, necessitating operative repair.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s10029-024-03118-5 | DOI Listing |
Open Heart
September 2025
Cardiology Department, Sahlgrenska University Hospital, Gothenburg, Sweden.
Aims: We investigated the prevalence of coronary microvascular dysfunction (CMD) and its association with severity of heart failure in patients with reduced or mildly reduced ejection fraction (HFrEF and HFmrEF).
Method: Patients with stable, symptomatic heart failure with left ventricular ejection fraction (LVEF) <50% were enrolled. Data collection included physical examination, blood samples, Kansas City Cardiomyopathy Questionnaire (KCCQ), carotid to femoral pulse wave velocity, echocardiography and adenosine-based transthoracic Doppler echocardiography to assess coronary flow reserve (CFR).
J Voice
August 2025
Departamento de Fonoaudiologia, Universidade Federal de Minas Gerais - UFMG, Belo Horizonte, MG, Brazil. Electronic address:
Objective: To analyze multiparametric acoustic indices (Acoustic Voice Quality Index [AVQI], Acoustic Breathiness Index [ABI], and Dysphonia Severity Index [DSI]) and cepstral peak prominence (CPP) and smoothed cepstral peak prominence (CPPS) measures according to sex and vocal quality in male and female teachers with normal laryngeal function. This analysis aims to deepen our understanding of these measures and their application in vocal assessments.
Methods: This cross-sectional observational study included 86 teachers without laryngeal disorders (48 females and 38 males) aged 23-55 years, recruited from the Superintendência Central de Perícia Médica e Saúde Ocupacional, Minas Gerais, Brazil.
J Clin Med
August 2025
Second Department of Internal Medicine, University of Toyama, Toyama 930-0194, Japan.
: Vericiguat, a soluble guanylate cyclase stimulator, reduces cardiovascular events in patients with heart failure with reduced ejection fraction following clinical deterioration against guideline-directed medical therapy. However, the optimal timing for initiating vericiguat remains unclear. : We retrospectively analyzed heart failure patients with reduced/mild-reduced ejection fraction who received vericiguat between 2021 and 2025 upon optimal guideline-directed medical therapy.
View Article and Find Full Text PDFJ Am Coll Cardiol
August 2025
Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA. Electronic address:
Background: Obesity is highly prevalent among individuals with heart failure with mildly reduced ejection fraction (HFmrEF) or heart failure with preserved ejection fraction (HFpEF) and is associated with increased risk of disability and death.
Objectives: The purpose of this study is to explore the association between different adiposity-related anthropometrics and clinical outcomes in this population.
Methods: In this participant-level pooled analysis of 5 international randomized trials that enrolled adults with HFmrEF/HFpEF, the association between adiposity-related anthropometrics (body mass index [BMI], waist circumference [WC], and waist-to-height ratio [WHtR]) and heart failure (HF) and mortality outcomes was evaluated, overall and by age and sex.